Talquetamab with Iberdomide
A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
More Information
- Trial Status
- Not yet accepting
- Trial Phase
- Phase 1
- Enrollment
- 38 patients (estimated)
- Sponsors
- University of California San Francisco
- Collaborators
- Bristol Myers Squibb, Janssen Research & Development LLC, Bristol Myers Squibb, Janssen Research & Development LLC
- Tags
- Bispecific Antibody, CD3, GPRC5D
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1877
- NCT Identifier
- NCT06348108
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.